TLDR
- UnitedHealth delivered Q1 adjusted EPS of $7.23, surpassing analyst expectations of $6.58, while revenue reached $111.7 billion versus $109.4 billion anticipated.
- Shares climbed 5.7% to $342 during Tuesday’s premarket session.
- Annual adjusted EPS forecast increased to above $18.25, compared to the previous $17.75 projection from January.
- Medical care ratio enhanced to 83.9% in Q1 2026, declining from 84.8% in the prior-year period.
- The company commits at least $1.5 billion toward AI initiatives to counteract a $6 billion Medicare reimbursement challenge.
UnitedHealth Group delivered impressive first-quarter performance, surpassing Wall Street projections for both profit and revenue while boosting its annual forecast. These results emerge as the healthcare giant advances its transformation initiative under CEO Stephen Hemsley, who resumed leadership last May.
First-quarter adjusted profit reached $7.23 per share, significantly exceeding the consensus projection of $6.58. Total revenue climbed to $111.7 billion, surpassing analyst forecasts of $109.4 billion. The company reported net income of $6.28 billion, translating to $6.90 per share.
Shares surged 5.7% to $342 during Tuesday’s premarket session.
UnitedHealth Group Incorporated, UNH
The company elevated its full-year adjusted EPS projection to more than $18.25, an increase from the $17.75 forecast issued in January. CFO Wayne DeVeydt informed Barron’s that additional guidance adjustments would likely wait until after the second quarter. “We’d like to just see a few more months get under our belt,” he noted.
UnitedHealthcare’s revenue expanded to $86.3 billion during the quarter, compared to $84.6 billion in the first quarter of 2025. Operating margin improved to 6.6%, up from 6.2% in the comparable year-ago period.
Medical Costs Show Improvement
Among the most encouraging indicators in the earnings release was the medical care ratio — representing the portion of premium revenue allocated to medical expenses. This metric decreased to 83.9% in Q1 2026 from 84.8% in Q1 2025. The improvement marks a substantial change after the ratio reached 91.5% in Q4 2025.
Management credited the enhancement to disciplined cost control and positive reserve development. However, increased utilization rates and higher unit costs partially moderated these gains.
UnitedHealth has been strategically retreating from unprofitable market segments, including individual ACA offerings and select Medicare Advantage regions. This strategic repositioning resulted in membership declining from 49.8 million at 2025 year-end to 49.1 million in Q1 2026. Medicare Advantage membership decreased by 965,000 during the quarter.
Optum and AI Investment
Optum Health, which faced challenges throughout most of 2025, generated $1.3 billion in adjusted operating earnings during Q1. DeVeydt characterized it as a “very good start” relative to full-year expectations of more than $1.6 billion. “We view this as a multiyear journey,” he explained.
UnitedHealth is allocating a minimum of $1.5 billion toward artificial intelligence initiatives this year. Management indicates these investments are instrumental in addressing a $6 billion challenge stemming from previous Medicare reimbursement modifications. DeVeydt stated the return on investment timeline for AI projects is “very short.”
Earlier this month, Medicare officials announced an average 2.48% payment increase for insurers in the upcoming year. UNH shares had already appreciated 9% following that announcement. DeVeydt recognized the increase “didn’t fully address” prevailing medical cost trends, indicating benefit reductions will remain necessary in 2026.
Morgan Stanley elevated UNH to a “top pick” designation on April 16, pointing to expectations for a “string of clean quarters” after the more advantageous Medicare rate disclosure.
UnitedHealthcare’s employer self-funded segment helped mitigate some membership declines, while the company’s OptumRx pharmacy benefit division also supported overall revenue expansion.
